Ozurdex 0.7 MG implants
Ended Awarded
- Contract number
- SPE2DX25F6XLH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,011
Award facts
- Contract value 100% obligated
- $2,010.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,010.76 for OZURDEX 0.7 mg implants on June 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation and includes a completion date of July 11, 2025, with performance at the company's Park Ridge, Illinois location. The delivery order supports the Defense-affiliated Medical Supply Chain, providing specialized pharmaceutical products to Department of Defense healthcare facilities.
As a crucial supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its status as a woman-owned small business to deliver a comprehensive range of pharmaceutical items to military health facilities nationwide. The OZURDEX implant is an ophthalmic medication used primarily for treating inflammatory conditions of the eye, and this delivery order reflects the company's role in providing specialty pharmaceutical products that support the medical supply needs of the Defense Department's healthcare systems. The firm's track record with the DLA demonstrates consistent capability in managing complex pharmaceutical procurement and distribution across the federal market.
Quick answers
Who was awarded contract SPE2DX25F6XLH?
SPE2DX25F6XLH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 18, 2025.
How much is contract SPE2DX25F6XLH worth?
The government has obligated $2,011 on SPE2DX25F6XLH.
Is contract SPE2DX25F6XLH an order under another contract?
Yes. SPE2DX25F6XLH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XLH competed?
The extent of competition for SPE2DX25F6XLH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award